drugset / Trial / NCT07318103
Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase II clinical study of HRS-9057 injection in patients with heart failure-induced fluid retention
Timeline
- Start
- 2025-12-31
- Primary completion
- 2026-07
- Completion
- 2026-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-9057 | Unknown | — | — |
Indications
No indication recorded.